セルカウンティングの世界市場レポート

セルカウンティング市場の世界需要は、2023年～2030年の調査期間中にCAGR9.56%で成長し、2022年の830万米ドルから2030年までに1,723万米ドル近い市場規模に達すると推定されます。

セルカウンティングは、様々な目的で細胞の濃度を測定するために使用されます。薬剤処理後や処理前の細胞の生存性を評価したり、細胞の健康状態を定性的に判断したり、亜集団を計数したり、データを取得して分析したりするために使用されます。セルカウンティングは手動で行われるか、培養中の生細胞や死細胞を計数する自動カウンターを通して行われます。

市場力学：

セルカウンティング市場成長の原動力は、主に先進国に集中する細胞ベースの研究に対する資金提供の増加です。これは主に、いくつかの慢性疾患や感染症の高い発生率、その検出、治療法や治療法の発見に基づいています。多くのバイオテクノロジーやバイオ医薬品産業は、この分野の研究開発に多額の投資を行っています。さらに、画像解析を向上させる技術の進歩や、ハイスループットなフローサイトメトリーや自動血液学分析装置の利用拡大により、市場は成長トレンドを維持すると予想されます。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールはセルカウンティングの世界市場における各セグメントを包括的に評価することもできます。セルカウンティング業界の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析：

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおけるセルカウンティング市場の現在と将来の需要を強調する地域展望をカバーします。さらに、著名な全地域における個々のアプリケーションセグメントの需要・推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

• 市場のハイライト
• 世界市場スナップショット

第3章 セルカウンティング：産業分析

• イントロダクション：市場力学
• 市場促進要因
• 市場抑制要因
• 機会
• 業界動向
• ポーターのファイブフォース分析
• 市場魅力度分析

第4章 バリューチェーン分析

• バリューチェーン分析
• 原材料分析
  • 原材料リスト
  • 原材料メーカーリスト
  • 主要原材料の価格動向
• 潜在的バイヤーのリスト
• マーケティングチャネル
  • ダイレクトマーケティング
  • インダイレクトマーケティング
  • マーケティングチャネル発展動向

第5章 セルカウンティングの世界市場分析：製品別

• 概要：製品別
• 実績データと予測データ
• 分析：製品別
• 消耗品および付属品（試薬、マイクロプレート、その他）
• 装置（分光光度計、フローサイトメーター、血液分析装置、セルカウンター、顕微鏡、その他）

第6章 セルカウンティングの世界市場分析：用途別

• 概要：用途別
• 実績データと予測データ
• 分析：用途別
• 完全血球計数（自動セルカウンター、手動セルカウンター）
• 幹細胞調査
• 細胞ベースの治療
• バイオプロセス
• 毒物学
• その他

第7章 セルカウンティングの世界市場分析：エンドユーザー別

• 概要：エンドユーザー別
• 実績データと予測データ
• 分析：エンドユーザー別
• 研究機関
• 病院・診断研究所
• 製薬・バイオテクノロジー企業
• その他のエンドユーザー

第8章 セルカウンティングの世界市場分析：地域別

• 地域別の展望
• イントロダクション
• 北米の売上分析
  • 概要、実績と予測
  • 北米：セグメント別
  • 北米：国別
  • 米国
  • カナダ
  • メキシコ
• 欧州の売上分析
  • 概要、実績と予測
  • 欧州：セグメント別
  • 欧州：国別
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • ロシア
  • その他欧州
• アジア太平洋地域の売上分析
  • 概要、実績と予測
  • アジア太平洋地域：セグメント別
  • アジア太平洋地域：国別
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• ラテンアメリカの売上分析
  • 概要、実績と予測
  • ラテンアメリカ：セグメント別
  • ラテンアメリカ：国別
  • ブラジル
  • アルゼンチン
  • ペルー
  • チリ
  • その他ラテンアメリカ
• 中東・アフリカの売上分析
  • 概要、実績と予測
  • 中東・アフリカ：セグメント別
  • 中東・アフリカ：国別
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東・アフリカ

第9章 セルカウンティング企業の競合情勢

• セルカウンティング市場の競合
• パートナーシップ/提携/協定
• 合併・買収
• 新製品発売
• その他の開発

第10章 企業プロファイル

• 企業シェア分析
• 市場集中度
• ThermoFisher Scientific Inc.
• Merck KGaA
• Agilent Technologies
• PerkinElmer Inc.
• BD
• Danaher
• Bio-Rad Laboratories Inc.
• BioTek Instruments Inc.
• GE Healthcare
• DeNovix Inc.

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product (USD MN)
• Consumables And Accessories (Reagents, Microplates, Others) Market Sales by Geography (USD MN)
• Instruments (Spectrophotometers, Flow Cytometers, Hematology Analyzers, Cell Counters, Microscopes, Others) Market Sales by Geography (USD MN)
• Analysis Market by Application (USD MN)
• Complete Blood Count (Automated Cell Counters, Manual Cell Counters) Market Sales by Geography (USD MN)
• Stem Cell Research Market Sales by Geography (USD MN)
• Cell Based Therapeutics Market Sales by Geography (USD MN)
• Bioprocessing Market Sales by Geography (USD MN)
• Toxicology Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by End Users (USD MN)
• Research Institutes Market Sales by Geography (USD MN)
• Hospitals & Diagnostic Laboratories Market Sales by Geography (USD MN)
• Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
• Other End Users Market Sales by Geography (USD MN)
• Global Cell Counting Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Cell Counting Report
• Market Research Process
• Market Research Methodology
• Global Cell Counting Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by End Users
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product (USD MN)
• Consumables And Accessories (Reagents, Microplates, Others) Market Sales by Geography (USD MN)
• Instruments (Spectrophotometers, Flow Cytometers, Hematology Analyzers, Cell Counters, Microscopes, Others) Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Complete Blood Count (Automated Cell Counters, Manual Cell Counters) Market Sales by Geography (USD MN)
• Stem Cell Research Market Sales by Geography (USD MN)
• Cell Based Therapeutics Market Sales by Geography (USD MN)
• Bioprocessing Market Sales by Geography (USD MN)
• Toxicology Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End Users (USD MN)
• Research Institutes Market Sales by Geography (USD MN)
• Hospitals & Diagnostic Laboratories Market Sales by Geography (USD MN)
• Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
• Other End Users Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

The global demand for Cell Counting Market is presumed to reach the market size of nearly USD 17.23 MN by 2030 from USD 8.3 MN in 2022 with a CAGR of 9.56% under the study period 2023 - 2030.

Cell counting is used to determine the concentration of cells for various purposes. It is used to assess cell viability after and before drug treatment, qualitatively determine the cell health or count subpopulations, and capture and analyze the data. Cell counting is done manually, or through an automatic counter to count live and/or dead cells in culture.

MARKET DYNAMICS:

The cell counting market growth is driven by increasing funding for cell-based research, majorly concentrated in developed countries. This is largely based on the high incidence rate of some chronic and infectious diseases, their detection and finding a cure or treatment. Many biotechnology and biopharmaceutical industries are investing heavily in the research and development in this field. Moreover, the technological advancement in improving image analysis and the growing use of high-throughput flow cytometry and automated haematology analyzers is anticipated to keep the market on the growth trend.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cell counting. The growth and trends of cell counting industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the cell counting market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Consumables And Accessories (Reagents, Microplates, Others)
• Instruments (Spectrophotometers, Flow Cytometers, Hematology Analyzers, Cell Counters, Microscopes, Others)

By Application

• Complete Blood Count (Automated Cell Counters, Manual Cell Counters)
• Stem Cell Research
• Cell Based Therapeutics
• Bioprocessing
• Toxicology
• Others

By End Users

• Research Institutes
• Hospitals & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Other End Users

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Cell Counting market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cell counting market include ThermoFisher Scientific Inc., Merck KGaA, Agilent Technologies, PerkinElmer Inc., BD, Danaher, Bio-Rad Laboratories Inc., BioTek Instruments Inc., GE Healthcare, DeNovix Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . CELL COUNTING - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End Users
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CELL COUNTING MARKET ANALYSIS BY PRODUCT

• 5.1 Overview by Product
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product
• 5.4 Consumables And Accessories (Reagents, Microplates, Others) Historic and Forecast Sales by Regions
• 5.5 Instruments (Spectrophotometers, Flow Cytometers, Hematology Analyzers, Cell Counters, Microscopes, Others) Historic and Forecast Sales by Regions

6 . GLOBAL CELL COUNTING MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Complete Blood Count (Automated Cell Counters, Manual Cell Counters) Historic and Forecast Sales by Regions
• 6.5 Stem Cell Research Historic and Forecast Sales by Regions
• 6.6 Cell Based Therapeutics Historic and Forecast Sales by Regions
• 6.7 Bioprocessing Historic and Forecast Sales by Regions
• 6.8 Toxicology Historic and Forecast Sales by Regions
• 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL CELL COUNTING MARKET ANALYSIS BY END USERS

• 7.1 Overview by End Users
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End Users
• 7.4 Research Institutes Historic and Forecast Sales by Regions
• 7.5 Hospitals & Diagnostic Laboratories Historic and Forecast Sales by Regions
• 7.6 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
• 7.7 Other End Users Historic and Forecast Sales by Regions

8 . GLOBAL CELL COUNTING MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE CELL COUNTING COMPANIES

• 9.1. Cell Counting Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF CELL COUNTING INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. ThermoFisher Scientific Inc.
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Merck KGaA
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Agilent Technologies
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. PerkinElmer Inc.
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. BD
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Danaher
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Bio-Rad Laboratories Inc.
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. BioTek Instruments Inc.
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. GE Healthcare
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. DeNovix Inc.
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies